TrialThe Lancet. Oncology2020

Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial.

Véronique Diéras et al.PubMed ↗Publisher ↗

No numbers read from the abstract.